Cargando…

Comment on ‘High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer'

Detalles Bibliográficos
Autores principales:	Ho-Yen, C, Bowen, R L, Kermorgant, S, Jones, J L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670484/ https://www.ncbi.nlm.nih.gov/pubmed/23674084 http://dx.doi.org/10.1038/bjc.2013.249

Ejemplares similares

High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer
por: Zagouri, F, et al.
Publicado: (2013)

The clinical and functional significance of c-Met in breast cancer: a review
por: Ho-Yen, Colan M, et al.
Publicado: (2015)

Response to: Comment on ‘Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'
por: Shin, Vivian Y, et al.
Publicado: (2016)

Prognostic value of androgen receptor expression in triple negative breast carcinomas: personal experience and comments on a review about “Triple-negative breast cancer: treatment challenges and solutions” by Collignon et al
por: Ieni, Antonio, et al.
Publicado: (2016)

Comment on ‘Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'—Methodological challenges in combining miRNAs as circulating biomarkers
por: Verderio, P, et al.
Publicado: (2016)

Triple-negative breast cancer that progressed as estrogen receptor-positive skin metastases
por: Lee, Sang Min, et al.
Publicado: (2015)

Immune responses during neoadjuvant chemotherapy in triple negative breast cancer
por: Ghallab, Ahmed
Publicado: (2020)

Syntelin inhibits triple-negative breast cancer cell proliferation and metastasis
por: Mullen, McKay, et al.
Publicado: (2021)

TP 53 status and estrogen receptor-beta in triple negative breast cancer management in Africa: Time to rethink regime management of triple negative breast cancer and save more lives in Nigeria
por: Nzegwu, Martin Arinzechukwu, et al.
Publicado: (2021)

Targeting MET and EGFR crosstalk signaling in triple-negative breast cancers
por: Linklater, Erik S., et al.
Publicado: (2016)

Transcriptional profiles of different states of cancer stem cells in triple-negative breast cancer
por: Liu, Mingshan, et al.
Publicado: (2018)

Comment on: The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer
por: Mesker, W E, et al.
Publicado: (2015)

A comment on prognostic factors in burns
por: Ewington, Ian, et al.
Publicado: (2021)

CircRNA DDX21 acts as a prognostic factor and sponge of miR‐1264/QKI axis to weaken the progression of triple‐negative breast cancer
por: Huang, Renhong, et al.
Publicado: (2022)

Neoadjuvant radiotherapy in triple-negative breast cancer: “the past should not steal the present or hide the future”
por: To, Nhu Hanh, et al.
Publicado: (2022)

Comment on: “Negative Pressure Wound Therapy Reduces Wound Breakdown and Implant Loss in Prepectoral Breast Reconstruction”
por: Olaiya, Oluwatobi R., et al.
Publicado: (2020)

MET and FASN as Prognostic Biomarkers of Triple Negative Breast Cancer: A Systematic Evidence Landscape of Clinical Study
por: Jiang, Weihua, et al.
Publicado: (2021)

A response to comment on prognostic factors in burns
por: Zieliński, Michał, et al.
Publicado: (2020)

Reponse to: comment on, ‘Tumour-stroma ratio (TSR) in oestrogen-positive breast cancer patients'
por: Downey, C L, et al.
Publicado: (2015)

The Triple-Negative Breast Cancer Database: an omics platform for reference, integration and analysis of triple-negative breast cancer data
por: Raju, Rajesh, et al.
Publicado: (2014)

ABTL0812 enhances antitumor effect of paclitaxel and reverts chemoresistance in triple‐negative breast cancer models
por: Polonio‐Alcalá, Emma, et al.
Publicado: (2022)

Comment on “Effect of dacryocystorhinostomy on systemic adverse effects of topical timolol maleate”
por: Arunachalam, Cynthia
Publicado: (2013)

Comment on ‘Existing prognostic models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma'
por: Kao, S C-H, et al.
Publicado: (2014)

Hindering triple negative breast cancer progression by targeting endogenous interleukin‐30 requires IFNγ signaling
por: Sorrentino, Carlo, et al.
Publicado: (2021)

A plasma SNORD33 signature predicts platinum benefit in metastatic triple-negative breast cancer patients
por: Wang, Biyun, et al.
Publicado: (2022)

HLF regulates ferroptosis, development and chemoresistance of triple-negative breast cancer by activating tumor cell-macrophage crosstalk
por: Li, Hengyu, et al.
Publicado: (2022)

Co-dependency for MET and FGFR1 in basal triple-negative breast cancers
por: Sung, Vanessa Y. C., et al.
Publicado: (2021)

Response to comment on ‘Existing prognostic models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma'
por: Meniawy, T M, et al.
Publicado: (2014)

Mutational characteristics determined using circulating tumor DNA analysis in triple‐negative breast cancer patients with distant metastasis
por: Rong, Guohua, et al.
Publicado: (2020)

Interfering with CSE1L/CAS inhibits tumour growth via C3 in triple‐negative breast cancer
por: Ye, Mei, et al.
Publicado: (2022)

UBQLN4 promotes STING proteasomal degradation during cisplatin‐induced DNA damage in triple‐negative breast cancer
por: Shoji, Yoshiaki, et al.
Publicado: (2022)

Comment on “Association of Intraoperative Red Blood Cell Transfusions With Venous Thromboembolism and Adverse Outcomes After Cardiac Surgery”
por: Butt, Amir L., et al.
Publicado: (2023)

Comment on “Effects of Scheduled Exercise on Cancer-Related Fatigue in Women with Early Breast Cancer”
por: Veal, Isla, et al.
Publicado: (2015)

c-Met inhibitors
por: Mughal, Anum, et al.
Publicado: (2013)

Comment on "Efficacy and adverse events of cold vs hot polypectomy: A meta-analysis"
por: Sun, Huan-Huan, et al.
Publicado: (2017)

Comments on Post‐pancreatitis diabetes mellitus is common in chronic pancreatitis and is associated with adverse outcomes
por: Yi, Jin‐Hui, et al.
Publicado: (2023)

Molecular characterisation of triple negative essential thrombocythaemia patients by platelet analysis and targeted sequencing
por: Angona, A, et al.
Publicado: (2016)

The Role of PI3K in Met Driven Cancer: A Recap
por: Hervieu, Alexia, et al.
Publicado: (2018)

c-Met-integrin cooperation: Mechanisms, tumorigenic effects, and therapeutic relevance
por: Stanislovas, Justas, et al.
Publicado: (2022)

Comment on: Hydatid cyst of the breast: Case report
por: Akbulut, Sami, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9g6jcgl7eoknhqgla82pod3akd